Search

Home > Lung Cancer Considered > Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC
Podcast: Lung Cancer Considered
Episode:

Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC
Category: Science & Medicine
Duration: 00:32:42
Publish Date: 2024-02-29 14:00:12
Description: Today’s episode of Lung Cancer Considered is part of our special series on seminal trials in thoracic oncology, focusing on the phase I study of the PD-1 inhibitor nivolumab. Hosts Dr. Narjust Florez and Dr. Stephen Liu discuss that study with guest Dr. Julie Brahmer from Johns Hopkins University. This podcast features surprise guest interviews with several doctors who were mentored by Dr. Brahmer.
Total Play: 0